Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

ZNTL

Zentalis Pharmaceuticals, Inc.

CIK 0001725160 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$3.83
↓ 0.01 (-0.39%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$274.15M
P/E Ratio
-1.96
EPS
-1.91
Dividend Yield
Not covered
52W Position
46%
Beta
1.97

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.91
P/S
Not covered
EV/Revenue
Not covered
ROE
-97.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 46%
$1.21$6.95

Latest Financials

2025-12-31 FY
Revenue
$0.00
Net Income
-$137.06M
Total Assets
$288.97M
Free Cash Flow
-$125.25M

Recent news